Integrating advanced microscopy techniques with AI-fueled computational imaging promises to capture brain activity with the depth and speed needed to advance understanding of neurological diseases.Read More
After making its mark as the first therapy approved for pseudobulbar affect (pathologic laughing and crying) in ALS and MS, Nuedexta is under study for additional uses in a range neurologic diseases.
There’s no arguing that rhBMP-2 forms bone. The latest research aims to learn whether its adverse effects outweigh its benefits, and in which types of spine fusion procedures the risk-benefit ratio is most favorable.
Even with an estimated 44 million people living with Alzheimer s disease (AD), relatively few new AD drugs are in development. Additionally, the failure rate for AD drug development is 99.6 percent from the years 2002 to 2012 and the number of AD drugs has been declining since 2009. In a new analysis published today, researchers say there is an urgent need to increase the number of agents entering the AD drug development pipeline.
Insights from 2-D MRS studies have ignited a quest to study chemical changes in large volumes of brain simultaneously using 3-D PEPSI imaging. And they hint at what’s possible with MRS at 7-tesla field strength.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The novel CAREN system allows safe challenging of rehab patients through scenarios in an immersive virtual environment. Early use centers on Parkinson disease and MS, but clinical and research applications may be boundless.
Cleveland Clinic surgeons share the first known report of the combined use of three advanced operative tools for intractable focal partial epilepsy. Recovery was swift for the 19-year-old patient.
7-tesla MRI imaging is taking neuropsychiatric research into new territory with awe-inspiring resolution — and the story of what’s involved in scanner installation is pretty impressive too.